Lactobacillus gasseri SBT2055 inhibits adipose tissue inflammation and intestinal permeability in mice fed a high-fat diet

Journal of Nutritional Science

Volumn 5, Issue , 2016, Pages

  Kawano, Michio ^a   Miyoshi, Masaya ^a   Ogawa, Akihiro ^a   Sakai, Fumihiko ^a   Kadooka, Yukio ^a  

^a SNOW BRAND MILK PRODUCTS CO LTD   (Japan)

Author keywords

Anti inflammation effects; Anti obesity effects; Diet induced obesity; Intestinal barrier function; Lactobacillus gasseri SBT2055

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN G ANTIBODY; PROBIOTIC AGENT; TUMOR NECROSIS FACTOR;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CACO-2 CELL LINE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DIET INDUCED OBESITY; EPIDIDYMIS FAT; FAT MASS; INTESTINE EPITHELIUM CELL; INTESTINE MUCOSA PERMEABILITY; LACTOBACILLUS GASSERI; MACROPHAGE ACTIVATION; MALE; MESENTERIC FAT; MOUSE; NONHUMAN; PERIRENAL FAT; PRIORITY JOURNAL; RETROPERITONEAL FAT; TRANSEPITHELIAL RESISTANCE;

EID: 85055111432     PISSN: 20486790     EISSN: None     Source Type: Journal    
DOI: 10.1017/jns.2016.12     Document Type: Article

References (42)

1. Gregor MF & Hotamisligil GS (2011) Inflammatory mechanisms in obesity. Annu Rev Immunol 29, 415–445.
2. Johnson AMF & Olefsky JM (2013) The origins and drivers of insulin resistance. Cell 152, 673–684.
3. Cani PD, Amar J, Iglesias MA, et al. (2007) Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56, 1761–1772.
4. Cani PD, Bibiloni R, Knauf C, et al. (2008) Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57, 1470–1481.
5. Nishida J, Ekataksin W, McDonnell D, et al. (1994) Ethanol exacerbates hepatic microvascular dysfunction, endotoxemia, and lethality in septic mice. Shock 1, 413–418.
6. Gäbele E, Dostert K, Hofmann C, et al. (2011) DSS induced colitis increases portal LPS levels and enhances hepatic inflammation and fibrogenesis in experimental NASH. J Hepatol 55, 1391–1399.
7. Mazzon E & Cuzzocrea S (2008) Role of TNF-α in ileum tight junction alteration in mouse model of restraint stress. Am J Physiol Gastrointest Liver Physiol 294, G1268–G1280.
8. Moreira APB, Alves RDM, Teixeira TFS, et al. (2015) Higher plasma lipopolysaccharide concentrations are associated with less favorable phenotype in overweight/obese men. Eur J Nutr 54, 1363–1370.
9. Trøseid M, Nestvold TK, Rudi K, et al. (2013) Plasma lipopolysaccharide is closely associated with glycemic control and abdominal obesity: evidence from bariatric surgery. Diabetes Care 36, 3627–3632.
10. Fujiwara S, Seto Y, Kimura A, et al. (2001) Establishment of orally-administered Lactobacillus gasseri SBT2055SR in the gastrointestinal tract of humans and its influence on intestinal microflora and metabolism. J Appl Microbiol 90, 343–352.
11. Takahashi H, Fujita T, Suzuki Y, et al. (2006) Monitoring and survival of Lactobacillus gasseri SBT2055 in the human intestinal tract. Microbiol Immunol 50, 867–870.
12. Usman, Hosono A (1999) Bile tolerance, taurocholate deconjugation, and binding of cholesterol by Lactobacillus gasseri strains. J Dairy Sci 82, 243–248.
13. Kadooka Y, Sato M, Imaizumi K, et al. (2010) Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial. Eur J Clin Nutr 64, 636–643.
14. Kadooka Y, Sato M, Ogawa A, et al. (2013) Effect of Lactobacillus gasseri SBT2055 in fermented milk on abdominal adiposity in adults in a randomised controlled trial. Br J Nutr 110, 1696–1703.
15. Miyoshi M, Ogawa A, Higurashi S, et al. (2014) Anti-obesity effect of Lactobacillus gasseri SBT2055 accompanied by inhibition of pro-inflammatory gene expression in the visceral adipose tissue in diet-induced obese mice. Eur J Nutr 53, 599–606.
16. Sato M, Uzu K, Yoshida T, et al. (2008) Effects of milk fermented by Lactobacillus gasseri SBT2055 on adipocyte size in rats. Br J Nutr 99, 1013–1017.
17. Kadooka Y, Ogawa A, Ikuyama K, et al. (2011) The probiotic Lactobacillus gasseri SBT2055 inhibits enlargement of visceral adipocytes and upregulation of serum soluble adhesion molecule (sICAM-1) in rats. Int Dairy J 21, 623–627.
18. American Institute of Nutrition (1977) Report of the American Institute of Nutrition ad hoc Committee on Standards for Nutritional Studies. J Nutr 107, 1340–1348.
19. Ukibe K, Miyoshi M & Kadooka Y (2015) Administration of Lactobacillus gasseri SBT2055 suppresses macrophage infiltration into adipose tissue in diet-induced obese mice. Br J Nutr 114, 1180–1187.
20. Cani PD, Possemiers S, Van de Wiele T, et al. (2009) Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 58, 1091–1103.
21. Suzuki T & Hara H (2010) Dietary fat and bile juice, but not obesity, are responsible for the increase in small intestinal permeability induced through the suppression of tight junction protein expression in LETO and OLETF rats. Nutr Metab (Lond) 7, 19.
22. Lumeng CN, Bodzin JL & Saltiel AR (2007) Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 117, 175–184.
23. Patsouris D, Li PP, Thapar D, et al. (2008) Ablation of CD11c-positive cells normalizes insulin sensitivity in obese insulin resistant animals. Cell Metab 8, 301–309.
24. Odegaard JI, Ricardo-Gonzalez RR, Goforth MH, et al. (2007) Macrophage-specific PPARγ controls alternative activation and improves insulin resistance. Nature 447, 1116–1120.
25. Nishimura S, Manabe I, Nagasaki M, et al. (2009) CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med 15, 914–920.
26. Rausch ME, Weisberg S, Vardhana P, et al. (2008) Obesity in C57BL/6J mice is characterized by adipose tissue hypoxia and cytotoxic T-cell infiltration. Int J Obes (Lond) 32, 451–463.
27. Fujisaka S, Usui I, Bukhari A, et al. (2009) Regulatory mechanisms for adipose tissue M1 and M2 macrophages in diet-induced obese mice. Diabetes 58, 2574–2582.
28. Shaul ME, Bennett G, Strissel KJ, et al. (2010) Dynamic, M2-like remodeling phenotypes of CD11c+ adipose tissue macrophages during high-fat diet-induced obesity in mice. Diabetes 59, 1171–1181.
29. Odegaard JI & Chawla A (2011) Alternative macrophage activation and metabolism. Annu Rev Pathol Mech Dis 6, 275–297.
30. Sica A & Mantovani A (2012) Macrophage plasticity and polarization: in vivo veritas. J Clin Invest 122, 787–795.
31. Sakai F, Hosoya T, Ono-Ohmachi A, et al. (2014) Lactobacillus gasseri SBT2055 induces TGF-β expression in dendritic cells and activates TLR2 signal to produce IgA in the small intestine. PLOS ONE 9, e105370.
32. Wang J, Tang H, Zhang C, et al. (2015) Modulation of gut microbiota during probiotic-mediated attenuation of metabolic syndrome in high fat diet-fed mice. ISME J 9, 1–15.
33. Jang SE, Han MJ, Kim SY, et al. (2014) Lactobacillus plantarum CLP-0611 ameliorates colitis in mice by polarizing M1 to M2-like macrophages. Int Immunopharmacol 21, 186–192.
34. Jang SE, Hyam SR, Han MJ, et al. (2013) Lactobacillus brevis G-101 ameliorates colitis in mice by inhibiting NF-κB, MAPK and AKT pathways and by polarizing M1 macrophages to M2-like macrophages. J Appl Microbiol 115, 888–896.
35. Lam YY, Ha CWY, Campbell CR, et al. (2012) Increased gut permeability and microbiota change associate with mesenteric fat inflammation and metabolic dysfunction in diet-induced obese mice. PLOS ONE 7, e34233.
36. Amar J, Chabo C, Waget A, et al. (2011) Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment. EMBO Mol Med 3, 559–572.
37. Schertzer JD, Tamrakar AK, Magalhães JG, et al. (2011) NOD1 activators link innate immunity to insulin resistance. Diabetes 60, 2206–2215.
38. Putaala H, Salusjärvi T, Nordström M, et al. (2008) Effect of four probiotic strains and Escherichia coli O157:H7 on tight junction integrity and cyclo-oxygenase expression. Res Microbiol 159, 692–698.
39. Stenman LK, Waget A, Garret C, et al. (2014) Potential probiotic Bifidobacterium animalis ssp. lactis 420 prevents weight gain and glucose intolerance in diet-induced obese mice. Benef Microbes 5, 437–445.
40. Li Z, Soloski MJ, Diehl AM, et al. (2005) Dietary factors alter hepatic innate immune system in mice with nonalcoholic fatty liver disease. Hepatology 42, 880–885.
41. Ulluwishewa D & Anderson R (2011) Regulation of tight junction permeability by intestinal bacteria and dietary components. J Nutr 141, 769–776.
42. Karczewski J, Troost FJ, Konings I, et al. (2010) Regulation of human epithelial tight junction proteins by Lactobacillus plantarum in vivo and protective effects on the epithelial barrier. Am J Physiol Gastrointest Liver Physiol 298, G851–G859.